TY - BOOK AU - Allegranzi, B. AU - Bagheri Nejad, S. AU - Combescure, C. AU - Graafmans, W. AU - Attar, H. AU - Donaldson, L. AU - Pittet, D. PY - 2011 DA - 2011// TI - Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis PB - Lancet CY - London, England ID - Allegranzi2011 ER - TY - JOUR AU - Sievert, D. M. AU - Ricks, P. AU - Edwards, J. R. AU - Schneider, A. AU - Patel, J. AU - Srinivasan, A. AU - Kallen, A. AU - Limbago, B. AU - Fridkin, S. PY - 2013 DA - 2013// TI - Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010 JO - Infection control and hospital epidemiology: the official journal of the Society of Hospital Epidemiologists of America VL - 34 UR - https://doi.org/10.1086/668770 DO - 10.1086/668770 ID - Sievert2013 ER - TY - BOOK PY - 2011 DA - 2011// TI - Antimicrobial resistance surveillance in Europe ID - ref3 ER - TY - JOUR AU - Flores-Mireles, A. L. AU - Walker, J. N. AU - Caparon, M. AU - Hultgren, S. J. PY - 2015 DA - 2015// TI - Urinary tract infections: epidemiology, mechanisms of infection and treatment options JO - Nat Rev Microbiol VL - 13 UR - https://doi.org/10.1038/nrmicro3432 DO - 10.1038/nrmicro3432 ID - Flores-Mireles2015 ER - TY - JOUR AU - Lo, E. AU - Nicolle, L. E. AU - Coffin, S. E. AU - Gould, C. AU - Maragakis, L. L. AU - Meddings, J. AU - Pegues, D. A. AU - Pettis, A. M. AU - Saint, S. AU - Yokoe, D. S. PY - 2014 DA - 2014// TI - Strategies to prevent catheter-associated urinary tract infections in acute care hospitals: 2014 update JO - Infection control and hospital epidemiology: the official journal of the Society of Hospital Epidemiologists of America VL - 35 UR - https://doi.org/10.1017/S0899823X00193845 DO - 10.1017/S0899823X00193845 ID - Lo2014 ER - TY - BOOK PY - 2012 DA - 2012// TI - Guidance for industry. Complicated urinary tract infections: Developing drugs for treatment ID - ref6 ER - TY - BOOK AU - Davis, N. AU - Flood, H. PY - 2011 DA - 2011// TI - The pathogenesis of urinary tract infections ID - Davis2011 ER - TY - JOUR AU - Nicolle, L. E. AU - Louie, T. J. AU - Dubois, J. AU - Martel, A. AU - Harding, G. K. AU - Sinave, C. P. PY - 1994 DA - 1994// TI - Treatment of complicated urinary tract infections with lomefloxacin compared with that with trimethoprim-sulfamethoxazole JO - Antimicrob Agents Chemother VL - 38 UR - https://doi.org/10.1128/AAC.38.6.1368 DO - 10.1128/AAC.38.6.1368 ID - Nicolle1994 ER - TY - JOUR AU - Hidron, A. I. AU - Edwards, J. R. AU - Patel, J. AU - Horan, T. C. AU - Sievert, D. M. AU - Pollock, D. A. AU - Fridkin, S. K. PY - 2008 DA - 2008// TI - NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007 JO - Infect Control Hosp Epidemiol VL - 29 UR - https://doi.org/10.1086/591861 DO - 10.1086/591861 ID - Hidron2008 ER - TY - JOUR AU - Kollef, M. H. AU - Sherman, G. AU - Ward, S. AU - Fraser, V. J. PY - 1999 DA - 1999// TI - Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients JO - Chest VL - 115 UR - https://doi.org/10.1378/chest.115.2.462 DO - 10.1378/chest.115.2.462 ID - Kollef1999 ER - TY - JOUR AU - Falagas, M. E. AU - Barefoot, L. AU - Griffith, J. AU - Ruthazar, R. AU - Snydman, D. R. PY - 1996 DA - 1996// TI - Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections JO - Eur J Clin Microbiol Infect Dis VL - 15 UR - https://doi.org/10.1007/BF01690508 DO - 10.1007/BF01690508 ID - Falagas1996 ER - TY - STD TI - WHO: Antimicrobial resistance: Global report on surveillance. In 2014. >http://www.who.int/drugresistance/documents/surveillancereport/en/. Accessed 21 Jan 2016. UR - http://www.who.int/drugresistance/documents/surveillancereport/en/ ID - ref12 ER - TY - JOUR AU - Edelsberg, J. AU - Berger, A. AU - Schell, S. AU - Mallick, R. AU - Kuznik, A. AU - Oster, G. PY - 2008 DA - 2008// TI - Economic consequences of failure of initial antibiotic therapy in hospitalized adults with complicated intra-abdominal infections JO - Surg Infect VL - 9 UR - https://doi.org/10.1089/sur.2006.100 DO - 10.1089/sur.2006.100 ID - Edelsberg2008 ER - TY - JOUR AU - Leekha, S. AU - Terrell, C. L. AU - Edson, R. S. PY - 2011 DA - 2011// TI - General principles of antimicrobial therapy JO - Mayo Clin Proc VL - 86 UR - https://doi.org/10.4065/mcp.2010.0639 DO - 10.4065/mcp.2010.0639 ID - Leekha2011 ER - TY - JOUR AU - Koningstein, M. AU - Bij, A. K. AU - Kraker, M. E. AU - Monen, J. C. AU - Muilwijk, J. AU - Greeff, S. C. AU - Geerlings, S. E. AU - Hall, M. A. PY - 2014 DA - 2014// TI - Recommendations for the empirical treatment of complicated urinary tract infections using surveillance data on antimicrobial resistance in the Netherlands JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0086634 DO - 10.1371/journal.pone.0086634 ID - Koningstein2014 ER - TY - STD TI - Grabe M, Bjerklund-Johansen TE, Botto H, Cek M, Naber KG, Tenke P, Wagenlehner F. Guidelines on urological infections. In: European Association of Urology. 2010; ID - ref16 ER - TY - JOUR AU - Hsueh, P. R. AU - Hoban, D. J. AU - Carmeli, Y. AU - Chen, S. Y. AU - Desikan, S. AU - Alejandria, M. AU - Ko, W. C. AU - Binh, T. Q. PY - 2011 DA - 2011// TI - Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region JO - J Inf Secur VL - 63 ID - Hsueh2011 ER - TY - JOUR AU - Zhanel, G. G. AU - Chung, P. AU - Adam, H. AU - Zelenitsky, S. AU - Denisuik, A. AU - Schweizer, F. AU - Lagace-Wiens, P. R. AU - Rubinstein, E. AU - Gin, A. S. AU - Walkty, A. PY - 2014 DA - 2014// TI - Ceftolozane/tazobactam: a novel cephalosporin/beta-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilli JO - Drugs VL - 74 UR - https://doi.org/10.1007/s40265-013-0168-2 DO - 10.1007/s40265-013-0168-2 ID - Zhanel2014 ER - TY - STD TI - Sader HS, Farrell DJ, Flamm RK, Jones RN. Ceftolozane/tazobactam activity tested against aerobic Gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012). J Infect. 2014;69(3):266-77. ID - ref19 ER - TY - BOOK AU - Basu, A. PY - 2016 DA - 2016// TI - Estimating costs and valuations of non-health benefits in cost-effectiveness analysis, in chapter 8, second panel on cost-effectiveness analysis in health and medicine: Oxford university press; forthcoming ID - Basu2016 ER - TY - STD TI - AMCP. The AMCP Format For Formulary Submissions Version 3.1. In; 2012. http://www.amcp.org/practice-resources/amcp-format-formulary-submisions.pdf. Accessed 21 Jan 2016. UR - http://www.amcp.org/practice-resources/amcp-format-formulary-submisions.pdf ID - ref21 ER - TY - BOOK AU - Wagenlehner, F. M. AU - Umeh, O. AU - Steenbergen, J. AU - Yuan, G. AU - Darouiche, R. O. PY - 2015 DA - 2015// TI - Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI) PB - Lancet CY - London ID - Wagenlehner2015 ER - TY - JOUR AU - MacVane, S. H. AU - Tuttle, L. O. AU - Nicolau, D. P. PY - 2014 DA - 2014// TI - Impact of extended-spectrum beta-lactamase-producing organisms on clinical and economic outcomes in patients with urinary tract infection JO - J Hosp Med VL - 9 UR - https://doi.org/10.1002/jhm.2157 DO - 10.1002/jhm.2157 ID - MacVane2014 ER - TY - STD TI - United States Life Tables http://www.cdc.gov/nchs/products/life_tables.htm. Accessed 21 Jan 2016. UR - http://www.cdc.gov/nchs/products/life_tables.htm ID - ref24 ER - TY - STD TI - 2012 Healthcare Cost and Utilization Project (HCUP). https://hcupnet.ahrq.gov/. Accessed 10 Nov 2014. UR - https://hcupnet.ahrq.gov/ ID - ref25 ER - TY - STD TI - Analy$ource Suite of Drug Pricing Services https://www.analysource.com. Accessed 21 Jan 2016. UR - https://www.analysource.com ID - ref26 ER - TY - STD TI - Using appropriate price indices for analyses of health care expenditures or income across multiple years. http://meps.ahrq.gov/about_meps/Price_Index.shtml. Accessed 21 Jan 2016. UR - http://meps.ahrq.gov/about_meps/Price_Index.shtml ID - ref27 ER - TY - JOUR AU - Jansen, J. P. AU - Kumar, R. AU - Carmeli, Y. PY - 2009 DA - 2009// TI - Cost-effectiveness evaluation of ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections accounting for antibiotic resistance JO - Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research VL - 12 UR - https://doi.org/10.1111/j.1524-4733.2008.00439.x DO - 10.1111/j.1524-4733.2008.00439.x ID - Jansen2009 ER - TY - STD TI - Zerbaxa U.S. Prescribing Information [http://www.merck.com/product/usa/pi_circulars/z/zerbaxa/zerbaxa_pi.pdf]. Accessed 21 Jan 2016. UR - http://www.merck.com/product/usa/pi_circulars/z/zerbaxa/zerbaxa_pi.pdf ID - ref29 ER - TY - STD TI - Framework Summary [http://icer-review.org/wp-content/uploads/2016/02/Value-Assessment-Framework-One-Pager.pdf]. UR - http://icer-review.org/wp-content/uploads/2016/02/Value-Assessment-Framework-One-Pager.pdf ID - ref30 ER - TY - JOUR AU - Marchaim, D. AU - Gottesman, T. AU - Schwartz, O. AU - Korem, M. AU - Maor, Y. AU - Rahav, G. AU - Karplus, R. AU - Lazarovitch, T. AU - Braun, E. AU - Sprecher, H. PY - 2010 DA - 2010// TI - National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamases JO - Antimicrob Agents Chemother VL - 54 UR - https://doi.org/10.1128/AAC.00565-10 DO - 10.1128/AAC.00565-10 ID - Marchaim2010 ER - TY - JOUR AU - Aloush, V. AU - Navon-Venezia, S. AU - Seigman-Igra, Y. AU - Cabili, S. AU - Carmeli, Y. PY - 2006 DA - 2006// TI - Multidrug-resistant Pseudomonas Aeruginosa: risk factors and clinical impact JO - Antimicrob Agents Chemother VL - 50 UR - https://doi.org/10.1128/AAC.50.1.43-48.2006 DO - 10.1128/AAC.50.1.43-48.2006 ID - Aloush2006 ER - TY - JOUR AU - Sader, H. S. AU - Mallick, R. AU - Kuznik, A. AU - Fritsche, T. R. AU - Jones, R. N. PY - 2007 DA - 2007// TI - Use of in vitro susceptibility and pathogen prevalence data to model the expected clinical success rates of tigecycline and other commonly used antimicrobials for empirical treatment of complicated skin and skin-structure infections JO - Int J Antimicrob Agents VL - 30 UR - https://doi.org/10.1016/j.ijantimicag.2007.07.020 DO - 10.1016/j.ijantimicag.2007.07.020 ID - Sader2007 ER - TY - STD TI - Lin HA, Yang YS, Wang JX, Lin HC, Lin Y, Chiu CH, Yeh KM, Lin JC, Chang FY. Comparison of the effectiveness and antibiotic cost among ceftriaxone, ertapenem, and levofloxacin in treatment of community-acquired complicated urinary tract infections. J Microbiol Immunol Infect. 2015; ID - ref34 ER - TY - STD TI - 2013 Healthcare Cost and Utilization Project (HCUP). [http://hcupnet.ahrq.gov/]. UR - http://hcupnet.ahrq.gov ID - ref35 ER -